POTENTIAL USES OF INTERLEUKIN-2 IN CANCER-THERAPY

被引：30

作者：

CHEEVER, MA

THOMPSON, JA

PEACE, DJ

GREENBERG, PD

机构：

[1] UNIV WASHINGTON,DEPT MICROBIOL IMMUNOL,SEATTLE,WA 98195

[2] FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104

来源：

IMMUNOBIOLOGY | 1986年 / 172卷 / 3-5期

关键词：

D O I：

10.1016/S0171-2985(86)80118-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：365 / 382

页数：18

共 50 条

[1] STUDIES ON CHEMICALLY-INDUCED RAT-TUMORS .2. PARTIAL PROTECTION AGAINST SYNGENEIC LETHAL TUMORS BY CLONED SYNGENEIC CYTO-TOXIC LYMPHOCYTES-T [J].

BINZ, H ;

FENNER, M ;

ENGEL, R ;

WIGZELL, H .

INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (04) :491-500

[2]

BONNARD GD, 1979, J IMMUNOL, V123, P2704

[3] INVIVO LOCALIZATION OF CLONED IL-2-DEPENDENT T-CELLS [J].

CARROLL, AM ;

PALLADINO, MA ;

OETTGEN, H ;

DESOUSA, M .

CELLULAR IMMUNOLOGY, 1983, 76 (01) :69-80

[4] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J].

CHEEVER, MA ;

GREENBERG, PD ;

FEFER, A ;

GILLIS, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) :968-980

[5]

CHEEVER MA, 1984, J BIOL RESP MODIF, V3, P462

[6]

CHEEVER MA, 1985, J IMMUNOL, V134, P3895

[7]

CHEEVER MA, 1981, J IMMUNOL, V126, P1318

[8]

CHEEVER MA, 1984, J IMMUNOL, V132, P2259

[9]

CHEEVER MA, 1986, J EXP MED, V63, P1100

[10]

CHEEVER MA, 1985, IMMUNITY CANCER, V8, P1

← 1 2 3 4 5 →